HOME › DRUGS › RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION F PROTEIN, ADJUVANTED WITH AS01E
ACTIVE SUBSTANCE / INN

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION F PROTEIN, ADJUVANTED WITH AS01E

Brand name(s): Arexvy
EMA LISTED
AUTHORISED
Respiratory Syncytial Virus Infections
ACTIVE SUBSTANCE
Recombinant Respiratory Syncytial Virus Pre-Fusion F Protein, Adjuvanted With As01E
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Biologicals S.A.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ArexvyGlaxoSmithKline Biologicals S.A.Authorised06/06/2023Respiratory Syncytial Virus Infections

FULL INTELLIGENCE ON RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION F PROTEIN, ADJUVANTED WITH AS01E

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →